290 episodes

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

IMID Rheumatology The IMID Forum

    • Education
    • 5.0 • 9 Ratings

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

    AxSpA Podcast: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

    AxSpA Podcast: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

    Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the risk of acute anterior uveitis across different bDMARDs in patients with AS. Our faculty then move on to discuss another publication, which compares patient-reported outcomes (PROs) and 24-month retention rates between patients with axSpA and PsA that were treated with secukinumab.

    • 32 min
    Discussing Rheumatology: February 2024

    Discussing Rheumatology: February 2024

    Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that show the long-term safety and efficacy of JAK inhibitors, both of which have a study period of 6.5 years. In our first paper, Roberto Caporali and colleagues show long-term safety and efficacy data for baricitinib as an RA therapy. Our second paper is from Christina Charles-Schoeman and her colleagues, where they present long-term data on the effect of upadacitinib on laboratory parameters in people with RA. To access detailed summary slides for the papers discussed today, visit imidforum.com.

    • 10 min
    PsA Podcast: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs

    PsA Podcast: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs

    Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the clinical response to guselkumab and the research surrounding sequential lines of b/tsDMARDs.

    • 32 min
    Author Interview: Dr Mahta Mortezavi, 2024

    Author Interview: Dr Mahta Mortezavi, 2024

    Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Mahta Mortezavi, a Clinical Director for Drug Discovery and Early Development as part of the Anti-infectives Research Unit at Pfizer, as they discuss her recent paper ‘Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumour necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance.’

    • 20 min
    Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs

    Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs

    Join Professor Peter Nash from the Griffith University in Brisbane, as well as Professors Andrew Cope, Professor of Rheumatology and Head of the Centre for Rheumatic Diseases at Kings College London, Professor Paul Emery, Clinical Professor and Director of the Leeds Biomedical Research Centre, and Professor John Isaacs, Professor of clinical immunology and Director of Newcastle Biomedicine Versus Arthritis Experimental Arthritis Treatment Centre.

    Together they discuss the recent paper ‘Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial’, published in The Lancet on 13th February 2024.

    • 43 min
    Author Interview: Dr Kehinde Sunmboye, 2024

    Author Interview: Dr Kehinde Sunmboye, 2024

    Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Kehinde Sunmboye, a consultant rheumatologist at the University Hospitals of Leicester NHS Trust, in this episode of the Author Interview series. Dr Sunmboye discusses his recent paper 'Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population' with Professor Nash in this exclusive interview.

    • 18 min

Customer Reviews

5.0 out of 5
9 Ratings

9 Ratings

Top Podcasts In Education

A Little Bit Richer
Legal & General
On Your Marks
ACCA
The Mel Robbins Podcast
Mel Robbins
Own Your Health
Katie Brindle
The Rich Roll Podcast
Rich Roll
TED Talks Daily
TED

You Might Also Like

Rheumnow Podcast
Dr. Cush
ACR Journals On Air
American College of Rheumatology
ACR on Air
American College of Rheumatology
Talking Rheumatology Spotlight
British Society for Rheumatology
Healio Rheuminations
Adam J. Brown, MD
The Evidence Based Rheumatology Podcast
Michael Putman